Literature DB >> 3023703

Modification of acute murine cytomegalovirus adrenal gland infection by adoptive spleen cell transfer.

J D Shanley.   

Abstract

Homozygous (nu/nu), athymic nude mice, infected with murine cytomegalovirus (MCMV), develop unremitting and ablative virus infection involving both the adrenal cortex and medulla. During acute infection, adoptive transfer of MCMV-immune, but not naive, spleen cells suppressed virus replication in the adrenal glands, but not the lungs or salivary gland. T lymphocytes, not macrophages or B cells, were responsible for limiting viral replication. The effect by donor cells was restricted by compatibility at the major histocompatibility locus. Restriction of MCMV replication in the adrenal gland was associated with T lymphocytes of the L3T4 phenotype. Thus, T-cell immunity is critical in regulating MCMV replication in the adrenal glands, and T lymphocytes restricted by class II major histocompatibility antigens mediate this effect.

Entities:  

Mesh:

Year:  1987        PMID: 3023703      PMCID: PMC255192     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Cytotoxic T lymphocyte response to murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz; F A Ennis
Journal:  Nature       Date:  1978-06-15       Impact factor: 49.962

Review 2.  Cytolytic T lymphocytes.

Authors:  M Nabholz; H R MacDonald
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

3.  The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection.

Authors:  J D Shanley; E L Pesanti
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

4.  Comparison of the pathogenesis of murine cytomegalovirus in lung and liver following intraperitoneal or intratracheal infection.

Authors:  M K Selgrade; A M Collier; L Saxton; M J Daniels; J A Graham
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

5.  H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.

Authors:  R M Zinkernagel; R M Welsh
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

6.  Therapeutic effect of acyclovir (ZoviraxTM) on the pathogenesis of chronic murine cytomegalovirus infection in the immunodeficient nude mouse.

Authors:  P Carthew
Journal:  Br J Exp Pathol       Date:  1982-12

7.  Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus.

Authors:  M Ho
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

8.  A human helper-dependent influenza virus-specific cytotoxic T lymphocyte clone restricted by HLA-DR2.

Authors:  B Fleischer
Journal:  Tissue Antigens       Date:  1985-10

9.  Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.

Authors:  H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Effects of hormones on the adrenal necrosis produced by Besnoitia jellisoni in golden hamsters.

Authors:  J K FRENKEL
Journal:  J Exp Med       Date:  1956-03-01       Impact factor: 14.307

View more
  5 in total

1.  Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors.

Authors:  M J Reddehase; S Jonjić; F Weiland; W Mutter; U H Koszinowski
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 2.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

3.  CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity.

Authors:  M J Reddehase; W Mutter; K Münch; H J Bühring; U H Koszinowski
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Therapy of a fatal murine cytomegalovirus infection with thymic humoral factor (THF-gamma 2) treated immune spleen cells.

Authors:  B Rager-Zisman; F Zuckerman; D Benharroch; M Pecht; Y Burstein; N Trainin
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

5.  Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes.

Authors:  S Jonjić; I Pavić; P Lucin; D Rukavina; U H Koszinowski
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.